Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data
Authors:
Open Access
- 25 March 2017
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (26) , 43521-43535
Abstract
Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA dataKeywords
This publication has 50 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Significance of Heparanase in Cancer and InflammationCancer Microenvironment, 2011
- Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasisThe FEBS Journal, 2010
- Tamoxifen Induces Heparanase Expression in Estrogen Receptor–Positive Breast CancerClinical Cancer Research, 2007
- Heparanase expression correlates with poor survival in metastatic ovarian carcinomaGynecologic Oncology, 2007
- Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesisThe International Journal of Biochemistry & Cell Biology, 2006
- Heparanase promotes growth, angiogenesis and survival of primary breast tumorsInternational Journal of Cancer, 2005
- Ductal carcinoma in situ of the breast and heparanase-1 expression: A molecular explanation for more aggressive subtypesJournal of the American College of Surgeons, 2005
- Heparanase Gene Silencing, Tumor Invasiveness, Angiogenesis, and MetastasisJNCI: Journal of the National Cancer Institute, 2004
- Heparanase as mediator of angiogenesis: mode of actionThe FASEB Journal, 2001